Amid Purdue Pharma Legal Battles, Calls for Comprehensive Mass Tort Legislation Intensify
Washington – The recent Purdue Pharma ruling has reignited discussions on the urgent need for reform in the mass tort litigation system across the United States, spotlighting deep-seated issues impacting both plaintiffs and defendants. While specific cases, such as the opioid crisis lawsuits, bring to light individual corporate misconduct, they also underscore a wider systemic challenge that demands attention irrespective of single case outcomes. Mass tort cases involve lawsuits where numerous plaintiffs are directed against one or a few corporate defendants. Typically, these cases arise from claims where parties allege harm from products such as … Read more